The role of CD200-CD200R in tumor immune evasion
From MaRDI portal
Publication:2634979
DOI10.1016/j.jtbi.2013.03.017zbMath1330.92024OpenAlexW1975672782WikidataQ45931204 ScholiaQ45931204MaRDI QIDQ2634979
Kang-Ling Liao, Xue-Feng Bai, Avner Friedman
Publication date: 11 February 2016
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2013.03.017
Related Items (6)
Mathematical modeling and analysis of CD200-CD200R in cancer treatment ⋮ Different mechanisms of CD200-CD200R induce diverse outcomes in cancer treatment ⋮ A study of qualitative correlations between crucial bio-markers and the optimal drug regimen of Type I lepra reaction: a deterministic approach ⋮ Implications of immune-mediated metastatic growth on metastatic dormancy, blow-up, early detection, and treatment ⋮ Mathematical modeling of tumor growth: the MCF-7 breast cancer cell line ⋮ Mathematical modeling of tumor growth and treatment: triple negative breast cancer
Cites Work
- Modeling the inhibition of breast cancer growth by GM-CSF
- Transformed epithelial cells and fibroblasts/myofibroblasts interaction in breast tumor: a mathematical model and experiments
- A mathematical model for pattern formation of glioma cells outside the tumor spheroid core
- A methodology for performing global uncertainty and sensitivity analysis in systems biology
- Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: a mathematical model
- Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites
- The human immune response to \textit{Mycobacterium tuberculosis} in lung and lymph node
- A mathematical model of tumour angiogenesis, regulated by vascular endothelial growth factor and the angiopoietins
- Modelling the interactions between tumour cells and a blood vessel in a microenvironment within a vascular tumour
This page was built for publication: The role of CD200-CD200R in tumor immune evasion
